
Cindy Anne Leissinger MD
Professor, Medicine, Tulane University School of Medicine
Join to view full profile
1415 Tulane AveHC62New Orleans, LA 70112
Phone+1 504-988-6300
Fax+1 504-988-6348
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cindy Leissinger, MD is an oncologist in New Orleans, Louisiana. She is currently licensed to practice medicine in Louisiana and Texas. She is a Professor at Tulane University School of Medicine.
Education & Training
Tulane UniversityFellowship, Hematology and Medical Oncology, 1990
Tulane UniversityResidency, Internal Medicine, 1979 - 1982
Tulane University School of MedicineClass of 1979
Certifications & Licensure
LA State Medical License 1979 - 2026
TX State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2013, 2015-2017
Publications & Presentations
PubMed
- 3 citationsLack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk.Pooja Vir, Devi Gunasekera, Batsukh Dorjbal, Dennis McDaniel, Atul Agrawal
Journal of Thrombosis and Haemostasis. 2024-12-01 - 2 citationsAnother Victory for Patients with Hemophilia.Cindy Leissinger
The New England Journal of Medicine. 2023-01-26 - 4 citationsHemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life.Miguel A Escobar, Cindy Leissinger, Guy Young
Journal of the Advanced Practitioner in Oncology. 2022-05-01
Press Mentions
Efanesoctocog Alfa Reduces Bleeding, Pain in Phase 3 StudyJanuary 27th, 2023
New Hemophilia Treatment a Victory for Patients, Tulane Doctor Writes in New England Journal of MedicineJanuary 26th, 2023
New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia AJanuary 25th, 2023